谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.
研究兴趣

论文共 235 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Efficacy and Safety of Tarlatamab in a Patient with Advanced Delta-Like Ligand 3-Positive Large Cell Neuroendocrine Lung Carcinoma and Untreated Brain Metastases: A Case Report
Eleonora Gariazzo, Sanna Laaksonen, Stephanie Canty, Guilherme Rossato De Almeida,Igor Odintsov, Valentina Santo, Edoardo Garbo,Federica Pecci, Mihaela Aldea,Matthew G Oser,Lynette Sholl, Jacob M Sands,Biagio Ricciuti
JCO precision oncology (2025): e2500184-e2500184
引用0浏览0WOS引用
0
0
Antitumor Activity of Vebreltinib and Characterization of Clinicogenomic Features in Solid Tumors with MET Rearrangements
Seshiru Nakazawa,Federica Pecci,Igor Odintsov, Dimitris Gazgalis, Felix H Gottlieb,Biagio Ricciuti,Lodovica Zullo, Joao V Alessi,Alessandro Di Federico,Mihaela Aldea, Edoardo Garbo, Malini M Gandhi, Arushi Saini, William W Feng,Jie Jiang, Simon Baldacci,Francesco Facchinetti,Maisam Makarem, Marie-Anaïs Locquet,Koji Haratani, Danielle Haradon,Benjamin Besse,Antoine Italiano,Jordi Remon,Pernelle Lavaud,Damien Vasseur,David Planchard,Yusuke Sato, Yukako Watanabe,Scott Owen,Alexis B Cortot, Hoda Mahran, Martin D Forster,Jiaxin Niu,Pascale Tomasini, Swan,Kevin Tay,Emilio Esteban,Anna Minchom,Sani H Kizilbash,Marcia Cruz-Correa, Kin-Hung Peony Yu, Xiaoling Zhang, Pan Chen, Mythili Sangem,Jianwei Che, Lynette M Sholl,Pasi A Jänne, Mark M Awad
Cancer discoveryno. 6 (2025): 1129-1140
引用0浏览0WOS引用
0
0
Neoadjuvant PD-1 and PD-L1 Blockade with Chemotherapy for Borderline Resectable and Unresectable Stage III Non-Small Cell Lung Cancer
Biagio Ricciuti, Francesca Fusco, Alissa Cooper, Edoardo Garbo,Federica Pecci,Mihaela Aldea, Xinan Wang, Maria Mayoral Penalva, Michelle Ginsberg, Lynette M Sholl,Mizuki Nishino,Alessandro Di Federico,Narek Shaverdian, Matthew Bott, Valentina Santo, Erino Rendina,Rocco Trisolini,Sara Ramella, Filippo Gallina,Enrico Melis,Simonetta Buglioni,Gabriele Minuti,Lorenza Landi, Paula A Ugalde Figueroa, Alice T Shaw,Jamie Chaft, Mark M Awad,Federico Cappuzzo
JAMA oncology (2025)
引用0浏览0WOS引用
0
0
Determinants of 5-Year Survival in Patients with Advanced NSCLC with PD-L1≥50% Treated with First-Line Pembrolizumab Outside of Clinical Trials: Results from the Pembro-real 5Y Global Registry
Alessio Cortellini,Leonardo Brunetti,Giuseppina Rita Di Fazio,Edoardo Garbo,David J. Pinato,Jarushka Naidoo,Artur Katz, Monica Loza,Joel W. Neal,Carlo Genova,Scott Gettinger,So Yeon Kim,Ritujith Jayakrishnan,Talal El Zarif,Marco Russano,Federica Pecci,Alessandro Di Federico,Mark Awad,Joao Alessi,Michele Montrone,Dwight Hall Owen,Diego Signorelli,Mary Jo Fidler,Mingjia Li,Andrea Camerini,Andrea De Giglio, Lauren Young,Bruno Vincenzi,Giulio Metro,Francesco Passiglia,Sai Yendamuri,Annalisa Guida,Michele Ghidini, Nichola O. Awosika,Andrea Napolitano,Claudia A. M. Fulgenzi,Salvatore Grisanti,Francesco Grossi,Armida D'Incecco,Eleni Josephides, Mieke Van Hemelrijck,Alessandro Russo,Alain Gelibter, Gianpaolo Spinelli,Monica Verrico,Bartlomiej Tomasik,Raffaele Giusti,Thomas Newsom-Davis,Emilio Bria,Martin Sebastian,Maximilian Rost,Martin Forster,Uma Mukherjee,Lorenza Landi,Francesca Mazzoni,Avinash Aujayeb, Manuel Dupont,Alessandra Curioni-Fontecedro,Rita Chiari,Francesco Pantano,Alessandro Morabito,Alessandro Leonetti,Alex Friedlaender,Alfredo Addeo,Federica Zoratto,Michele De Tursi,Luca Cantini,Elisa Roca,Giannis Mountzios,Luigi Della Gravara,Sukumar Kalvapudi,Alessandro Inno,Paolo Bironzo, Rafael Di Marco Barros, David O'Reilly, Jack Bell,Eleni Karapanagiotou,Isabelle Monnet,Javier Baena,Marianna Macerelli,Margarita Majem,Francesco Agustoni,Diego Luigi Cortinovis,Giuseppe Tonini,Gabriele Minuti,Chiara Bennati,Laura Mezquita,Teresa Gorria,Alberto Servetto,Teresa Beninato,Giuseppe Lo Russo,Jacobo Rogado, Laura Moliner,Federica Biello,Frank Aboubakar Nana,Anne-Marie Dingemans,Joachim G. J. Aerts,Roberto Ferrara,Valter Torri,Taher Abu Hejleh,Kazuki Takada,Abdul Rafeh Naqash,Marina Garassino,Solange Peters,Heather Wakelee,Amin H. Nassar,Biagio Ricciuti
JOURNAL FOR IMMUNOTHERAPY OF CANCERno. 2 (2025)
引用0浏览0WOS引用
0
0
加载更多
作者统计

#Papers: 234

#Citation: 645

H-Index: 13

G-Index: 23

Sociability: 7

Diversity: 2

Activity: 111

  • 合作者
  • 学生
  • 导师
暂无相似学者，你可以通过学者研究领域进行搜索筛选
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn